DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising breakthroughs across various clinical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, more dependable choice for therapeutic use, significantl